<p>Measurement of the SNA-binding fraction (F<sub>SNA+IgG</sub>) and ECL-binding fraction (F<sub>ECL+IgG</sub>) in Octagam IVIG (OCT), Gammagard IVIG (GG), mAb 6E10, and mAb 4G8 using CFCA (A) and the On-Chip method (B,C). Two different lots of mAb 4G8 are shown as 4G8a and 4G8b. Each IgG was enzymatically untreated (black bars), 2,6 sialyltransferase treated (2,6ST, light grey bars), and neuraminidase treated (NEU, dark grey bars). Error bars indicate standard deviations (n = 2). CFCA measurements of [IgG]<sub>FC_SNA</sub> did not meet either the QC or SE criteria and F<sub>SNA+IgG</sub> and are reported as zero (indicated with asterisk *). Statistical significant differences below p < 0.14 are shown for relevant comparisons, i.e. betweend...
Objectives: Accurate measurement of IgG subclass (IgGSc) levels are essential to aid in the diagnosi...
<p>(A) Addition of IgM and IgA to IgG. Polyclonal IgG isolated from serum was first profiled on the ...
A comparison of four different ligand-binding assay technology platforms (ELISA, Meso Scale Discover...
<p>On-Chip SPR measurement of (A) the SNA-binding fraction (F<sub>SNA+IgG</sub>) and (B) the ECL-bin...
The fraction of IgG antibodies with anti-oligomeric Aβ affinity and surface sialic acid was compared...
The fraction of IgG antibodies with anti-oligomeric Aβ affinity and surface sialic acid was compared...
A: Scheme of the affinity pull-down assay. IN: sample before fractionation, UB: unbound fraction (Si...
<p>A representative SPR On-Chip experiment of a 66-fold dilution of 4G8a in a flow cell with immobil...
Scheme of the affinity pull-down assay as in Fig 4. IN: sample before fractionation, UB: unbound fra...
It has been proposed that the anti-inflammatory effects of intravenous immunoglobulin (IVIG) might b...
<p>Sias-siglec mediated binding of AG83<sup>+Sias</sup> and UR6 with J774A.1 <b>(A)</b> and THP-1 <b...
Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use...
<p>CFCA raw SPR data and fits of 4G8a association using a 833-fold stock dilution in a flow cell wit...
Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use...
<p>(A) The binding activity of full-length mAb-3F6 to GP was evaluated in ELISA experiments, where a...
Objectives: Accurate measurement of IgG subclass (IgGSc) levels are essential to aid in the diagnosi...
<p>(A) Addition of IgM and IgA to IgG. Polyclonal IgG isolated from serum was first profiled on the ...
A comparison of four different ligand-binding assay technology platforms (ELISA, Meso Scale Discover...
<p>On-Chip SPR measurement of (A) the SNA-binding fraction (F<sub>SNA+IgG</sub>) and (B) the ECL-bin...
The fraction of IgG antibodies with anti-oligomeric Aβ affinity and surface sialic acid was compared...
The fraction of IgG antibodies with anti-oligomeric Aβ affinity and surface sialic acid was compared...
A: Scheme of the affinity pull-down assay. IN: sample before fractionation, UB: unbound fraction (Si...
<p>A representative SPR On-Chip experiment of a 66-fold dilution of 4G8a in a flow cell with immobil...
Scheme of the affinity pull-down assay as in Fig 4. IN: sample before fractionation, UB: unbound fra...
It has been proposed that the anti-inflammatory effects of intravenous immunoglobulin (IVIG) might b...
<p>Sias-siglec mediated binding of AG83<sup>+Sias</sup> and UR6 with J774A.1 <b>(A)</b> and THP-1 <b...
Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use...
<p>CFCA raw SPR data and fits of 4G8a association using a 833-fold stock dilution in a flow cell wit...
Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use...
<p>(A) The binding activity of full-length mAb-3F6 to GP was evaluated in ELISA experiments, where a...
Objectives: Accurate measurement of IgG subclass (IgGSc) levels are essential to aid in the diagnosi...
<p>(A) Addition of IgM and IgA to IgG. Polyclonal IgG isolated from serum was first profiled on the ...
A comparison of four different ligand-binding assay technology platforms (ELISA, Meso Scale Discover...